Inhibitory effect of triptolide on platelet derived growth factor-A and coronary arteriosclerosis after heart transplantation.
Hachida
M
M
Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women's Medical College, Japan.
Lu
H
H
Zhang
X
X
Saito
S
S
Furutani
Y
Y
Matsuoka
R
R
Hoshi
H
H
Koyanagi
H
H
D000818:Animals; D003324:Coronary Artery Disease / Q000473:pathology / Q000517:prevention & control*; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology; D016572:Cyclosporine / Q000627:therapeutic use; D004224:Diterpenes / Q000627:therapeutic use*; D004852:Epoxy Compounds; D005786:Gene Expression Regulation; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D010616:Phenanthrenes; D010982:Platelet-Derived Growth Factor / Q000235:genetics*; D011183:Postoperative Complications; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D014184:Transplantation, Homologous
D004224:Diterpenes; D004852:Epoxy Compounds; D007166:Immunosuppressive Agents; D010616:Phenanthrenes; D010982:Platelet-Derived Growth Factor; C001899:triptolide; D016572:Cyclosporine